Navigation Links
Vaccine Pipeline Database: 1-Year Subscription
Date:10/6/2011

NEW YORK, Oct. 6, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Vaccine Pipeline Database: 1-Year Subscription

http://www.reportlinker.com/p0652031/Vaccine-Pipeline-Database-1-Year-Subscription.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Product description

Subscription to La Merie's proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of vaccines is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database.

Purchase of the subscription provides a 1-year online access to the data of the Antibody Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

Benefits from the Antibody Pipeline Database:

-New database (since 2008) with no historical burden

-Intuitive use

-Designed for structured searches

-Focused on targets, therapeutic areas and R&D phases

-Ideal for competitor analysis (companies, targets, product categories)

-Cost-effective and rapid solution for benchmarking

-Identification of licensing candidates

Project listing in a tabular format:

-Drug Codes

-Target / Mechanism of Action

-Class of Compound

-Product Category

-Company

-Territory

-Therapeutic Area

-Indication

-R&D Phase

Therapeutic Areas:

Cardiovascular & blood

Dermatology

Gastrointestinal

Genitourinary, renal & gynecology

Infectious & toxicology

Metabolism & endocrine

Neurology & psychiatry

Oncology

Ophthalmology & otorhinolaryngology

Orthopedics, dental, anesthesia & surgery

Pulmonary & respiratory

Rheumatoid & autoimmune

Examples of Predefined Targets of the Scroll Down Menu:

Hepatitis Vaccines

Influenza Vaccines

Herpes Virus Vaccines

Staphylococcal Aureus Vaccines

Streptococcal Vaccines

Pseudomonas Aeruginosa Vaccines

Cytomegalovirus (CMV) Vaccines

Tuberculosis Vaccines

Anthrax Vaccines

Respiratory Syncytial Virus (RSV) Vaccines

Human Papilloma Virus (HPV) Vaccines

Malaria Vaccines

Dengue Virus Vaccines

Human Immunodeficiency Virus (HIV) Vaccines

Therapeutic Cancer Vaccines

To order this report:

Drug and Medication Industry: Vaccine Pipeline Database: 1-Year Subscription

Drug and Medication Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
2. Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies
3. Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President
4. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
5. Nations Pharmacists Ready to Administer Seasonal Flu Vaccines
6. GlycoVaxyns Staphylococcus aureus Bioconjugate Vaccine Candidate Protects Mice Against Invasive S. aureus Infection
7. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
8. Initial Trial of Sanarias Malaria Vaccine Yields Positive Results
9. Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing
10. Anthem Blue Cross Kicks Off Statewide Series Of Free Whooping Cough Vaccine Clinics In Watts On Saturday
11. Pevion Grants CSL Option Right to its Therapeutic Candida Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... VIEW, Calif. , Feb. 10, 2016 ... of a synergistic confluence of various technologies ... value propositions, previously unavailable. These opportunities create ... and convergence, in turn, drives the development ... entrepreneurial scenario is characterized by technology convergences, ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... biopharmaceutical company developing novel, clinical-stage therapies for sickle cell ... an underwritten public offering of 29,090,910 units at a ... unit consists of one share of the Company,s common ... the Company,s common stock at an exercise price of ...
(Date:2/10/2016)... , Feb. 10, 2016 /PRNewswire/ - The President ... has announced the release of an anti-radiation product ... a revolutionary breakthrough in the treatment of cancer ... exposure. It will assist in the healing of ... It will also protect only the healthy cells ...
Breaking Medicine Technology:
(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 10, 2016 ... ... Programming (NLP) practitioner, is known locally for a series of therapeutic sessions to ... in-the-moment in their characters and in their lives. The series, known as “Mindfulness ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... unveiling its revolutionary new 2.0 version at the International Roofing Expo in Orlando, ... power of the world's most advanced weather technology in the hands of consumers, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... master charity program created to assist the local community. Pledging to select a ... and nonprofit organizations in the area. Their goal is to bring community awareness ...
(Date:2/10/2016)... ... ... Ongoing news of the ravages of traumatic brain injury (TBI) among former ... takes a closer look at cases of TBI being managed by their members. The ... the aging population, and identifies the challenges associated with their care. , During the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
Breaking Medicine News(10 mins):